SLC30A10
protein-codingsolute carrier family 30 member 10, the group of Solute carrier family 30
Gene summary
This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~273.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013208
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013208
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013208
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013208
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Gastrointestinal; Hematologic; Neurologic
Intervention: Hematologic
Rationale: The condition can involve hypermagnesemia, with gastrointestinal, neurologic, and other sequelae, and chelation therapy has been described as beneficial in some individuals
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC30A10 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018713.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 75 | 76 | |||
| missense | 1 | 2 | 125 | 8 | 136 | |
| nonsense | 1 | 2 | 3 | 6 | ||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 2 | 7 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 5 | 6 | 131 | 83 | 0 | 225 |
Highest pathogenic variant AF is 7.217538e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061183.2 | 4 | MANE Select | |
| Ensembl | ENSP00000355893.4 | 4 | MANE Select | |
| RefSeq | NP_001363858.1 | 4 | Standard | |
| RefSeq | NP_001402933.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| slc30a10 | Danio rerio | Structure: nucleate erythrocyte Quality: increased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Zinc homeostasis
- Transport of bile salts and organic acids, metal ions and amine compounds
- SLC-mediated transmembrane transport
- Transport of small molecules
- Metal ion SLC transporters
Biological Process
- manganese ion transport
- zinc ion transport
- epidermal growth factor receptor signaling pathway
- negative regulation of neuron apoptotic process
- positive regulation of ERK1 and ERK2 cascade
Molecular Function
- manganese ion transmembrane transporter activity
- protein binding
Cellular Component
- early endosome
- Golgi apparatus
- plasma membrane
- integral component of membrane
- recycling endosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366926
- Coding exons
- 4
- Length
- 273221
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.58 | 197 | 270 | 0.730 | 0.0000132 | 3119 |
| Missense (PolyPhen) | 39 | 87.104 | 0.44774 | 967 | ||
| Synonymous | 0.130 | 119 | 121 | 0.985 | 0.00000665 | 1017 |
| Loss of Function | 3.20 | 0 | 11.9 | 0.00 | 5.73e-7 | 147 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a pivotal role in manganese transport. Manganese is an essential cation for the function of several enzymes, including some crucially important for the metabolism of neurotransmitters and other neuronal metabolic pathways. However, elevated levels of manganese are cytotoxic and induce oxidative stress, mitochondrial dysfunction and apoptosis. Acts as manganese efflux transporter and confers protection against manganese- induced cell death (PubMed:22341972, PubMed:22341971, PubMed:25319704, PubMed:27226609, PubMed:27307044). Also acts as zinc transporter involved in zinc homeostasis. Seems to mediate zinc transport into early endosomes and recycling endosomes to prevent zinc toxicity; the function may be regulated by heterodimerization with other zinc transporters of the SLC30A subfamily. The SLC30A3:SLC30A10 heterodimer is involved in zinc transport-dependent regulation of the EGFR/ERK transduction pathway in endosomes. May be involved in regulation of zinc- dependent senescence of vascular smooth muscle cells (PubMed:22706290, PubMed:22427991, PubMed:26728129). {ECO:0000269|PubMed:22341971, ECO:0000269|PubMed:22341972, ECO:0000269|PubMed:22427991, ECO:0000269|PubMed:25319704, ECO:0000269|PubMed:27226609, ECO:0000305|PubMed:22706290}.;
- Disease
- DISEASE: Hypermanganesemia with dystonia 1 (HMNDYT1) [MIM:613280]: A metabolic autosomal recessive disorder characterized by dystonia, parkinsonism, extrapyramidal signs, severe hypermanganesemia, polycythemia, and chronic hepatic disease, including steatosis and cirrhosis. {ECO:0000269|PubMed:22341971, ECO:0000269|PubMed:22341972, ECO:0000269|PubMed:25319704}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- LoFtool
- 0.0689
- RVIS EVS
- -0.4
- RVIS percentile EVS
- 26.53
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0230
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |